Conventional clinical decision support systems are generally based on a single classifier or a simple combination of these models, showing moderate performance. In this paper, we propose a classifier ensemble-based method for supporting the diagnosis of cardiovascular disease (CVD) based on aptamer chips. This AptaCDSS-E system overcomes conventional performance limitations by utilizing ensembles of different classifiers. Recent surveys show that CVD is one of the leading causes of death and that significant life savings can be achieved if precise diagnosis can be made. For CVD diagnosis, our system combines a set of four different classifiers with ensembles. Support vector machines and neural networks are adopted as base classifiers. Decision trees and Bayesian networks are also adopted to augment the system. Four aptamer-based biochip data sets including CVD data containing 66 samples were used to train and test the system. Three other supplementary data sets are used to alleviate data insufficiency. We investigated the effectiveness of the ensemble-based system with several different aggregation approaches by comparing the results with single classifier-based models. The prediction performance of the AptaCDSS-E system was assessed with a cross-validation test. The experimental results show that our system achieves high diagnosis accuracy (>94%) and comparably small prediction difference intervals (<6%), proving its usefulness in the clinical decision process of disease diagnosis. Additionally, 10 possible biomarkers are found for further investigation.
1. Introduction
Background and motivation
Recent surveys show that cardiovascular disease (CVD), which includes heart disease and stroke, is one of the leading causes of death regardless of sex in the United States and all over the world (CDC's Report 1). From the report, CVD accounts for nearly 40% of all deaths in the US annually. While these largely preventable diseases are more prevalent among people aged more than 65, the number of sudden deaths from heart disease among people aged 15-34 has also increased substantially (CDC's Report 2). Therefore, significant life savings can be achieved if a precise diagnosis can be made to CVD patients. Correct diagnosis, however, is not easy to make and is often delayed due to the many factors complicating disease diagnosis. For example, clinical symptoms, functional, and pathologic manifestations of heart disease are often associated with many other human organs besides the heart itself, and often heart disease may show diverse syndromes. Furthermore, different types of heart disease can have similar symptoms, further complicating diagnosis (Yan, Jiang, Zheng, Peng, & Li, 2006) .
To reduce the time of intensive diagnosis and to improve diagnosis accuracy, the development of reliable and powerful clinical decision support systems (CDSSs) that support the aforementioned increasingly complicated diagnosis decision processes in the medical diagnosis is crucial (Yan 
Related work
In the last two decades, the use of artificial intelligence tools has become widely accepted in medical applications to support patient diagnosis more effectively. Especially, the application of various machine learning approaches such as decision trees (DTs), artificial neural networks (ANNs), Bayesian networks (BNs), and support vector machines (SVMs) have been actively tried for meeting clinical support requirements. Consequently, CDSS or medical diagnosis systems using different machine learning approaches have shown great potential, and many machine learning methods have been tried for a wide variety of clinical and medical applications. Here we briefly review some part of the previous work in this area before presenting our own machine-learning-based approach.
The use of decision trees is one of the most popularly applied methods for CDSS due to its simplicity and capacity for humanly understandable inductive rules. Many researchers have employed DT to resolve various biological problems, including diagnostic error analysis (Murphy, 2001) , potential biomarker finding (Qu et al., 2002; Won et al., 2003) , and proteomic mass spectra classification (Geurts et al., 2005) .
Bayesian networks are a probability-based inference model, increasingly used in the medical domain as a method of knowledge representation for reasoning under uncertainty for a wide range of applications, including disease diagnosis (Balla, Iansek, & Elstein, 1985) , genetic counseling (Harris, 1990) , expert system development (Stockwell, 1993) , gene network modeling (Liu, Sung, & Mittal, 2006) , and emergency medical decision support system (MDSS) design (Sadeghi, Barzi, Sadeghi, & King, 2006) .
Neural networks have also been applied to the medical and diagnosis fields, most actively as the basis of a soft computing method to render the complex and fuzzy cognitive process of diagnosis. Many applications, for example, have shown the suitability of neural networks in CDSS design and other biomedical application, including diagnosis of myocardial infarction (Baxt, 1990 (Baxt, , 1995 , differentiation of assorted pathological data (Dybowski & Gant, 1995) , MDSS for leukemia management (Chae, Park, Park, & Bae, 1998) and surgical decision support (Li, Liu, Chiu, & Jian, 2000) , MDSS for cancer detection (West & West, 2000) , assessment of chest-pain patients (Ellenius & Groth, 2000) , decision making for birth mode (MacDowell et al., 2001) , heart disease diagnosis (Tü rkoglu, Arslan, & Ilkay, 2002) , CDSS for pharmaceutical applications (Mendyk & Jachowicz, 2005) , CDSS development for gynecological diagnosis (Mangalampalli, Mangalampalli, Chakravarthy, & Jain, 2006) , and biological signal classification (Gü ven & Kara, 2006) . Recently, multilayer perceptrons (MLP), one of the most popular ANN models, has been applied to build an MDSS for five different heart diseases diagnoses (Yan et al., 2006) . The three-layered MLP with 40 categorical input variables and modified learning method achieved a diagnosis accuracy of over 90%.
Support vector machines are a new and promising classification and regression technique proposed by Vapnik and his co-workers (Cortes & Vapnik, 1995; Vapnik, 1995) . SVMs, developed in statistical learning theory, are recently of increasing interest to biomedical researchers. They are not only theoretically well-founded, but are also superior in practical applications. For medical, clinical decision support and biological domains, SVMs have been successfully applied to a wide variety of application domains, including MDSS for the diagnosis of tuberculosis infection (Veropoulos, Cristianini, & Campbell, 1999) , tumor classification (Schubert, Mü ller, Fritz, Lichter, & Eils, 2003) , myocardial infarction detection (Conforti & Guido, 2005) , biomarker discovery (Prados et al., 2004) , and cancer diagnosis (Majumder, Ghosh, & Gupta, 2005) .
Hybrid models. Besides single model-based approaches, hybrid machine learning approaches have also been tried to boost the performance of conventional single model methods and to overcome the inherent weaknesses in any single method. Many hybrid model approaches have been proposed, including a hybrid expert system for epileptic crisis decision using an ANN and a fuzzy method (Brasil, de Azevedo, & Barreto, 2001) , an ANN with a DT for the development of an intelligent decision support system (Tung, Huang, Chen, & Shih, 2005) , and an SVM with an ANN for electromyogram classification (Gü ler & Koçer, 2005) . Recently, a novel SVM method in combination with DT to generate human-understandable rules was proposed to alleviate the difficulty of understanding that arises from the black box characteristic of SVMs in transmembrane segments prediction (He, Hu, Harrison, Tai, & Pan, 2006) . Their approach achieved prediction accuracy of 93% with understandable prediction rules and with confidence values over 90%.
Ensemble models. To overcome the limited generalization performance of single models and simple model combination approaches, more precise model combination methods, called ''ensemble methods'', have been suggested. This multiple classifier combination is a technique that combines the decisions of different classifiers that are trained to solve the same problem but make different errors. Ensembles can reduce the variance of estimation errors and improve the overall classification accuracy. Many ensemble-based approaches have been proposed in recent research, including an ANN ensemble for decision support system (Ohlsson, 2004) , an ensemble of ANNs for breast cancer and liver disorder prediction (Yang & Browne, 2004) , MDSS with an ensemble of several different classifiers for breast diagnosis (West, Mangiameli, Rampal, & West, 2005) , and multiple classifier combinations with an evolutionary approach (Kim, Min, & Han, 2006 ).
Objective and scope of the present work
The majority of conventional CDSSs for disease diagnosis are generally based on the symptoms of the patient or data from simple medical questionnaires. To our knowledge, a CDSS for CVD diagnosis using an ensemble of multiple classifiers for comprehensive diagnosis and possible biomarker mining does not currently exist. The aim of this project is to develop a CDSS utilizing the expression information of physiological functional proteins with classifier ensembles for patient diagnosis. The patient's serum microarray chip data are analyzed with several different classifiers in the ensemble. The developed system, Apta-CDSS-E (Aptamer biochip-based CDSS -ensemble version), supports physicians by providing supplementary diagnosis information and clinicians by providing a possible set of biomarker candidates which can be used effectively for practical CVD diagnosis after some further experimental verifications.
The rest of the paper is organized as follows: In Section 2 we outline the system architecture, describe several key components of the system, and review the four basis classifiers used in our proposed system for disease level classification. In Section 3, the framework for constructing classifier ensembles is presented. Experimental results are reported in Section 4, including data description, preprocessing and feature selection, quality analysis of data, the possible marker proteins discovered by the system, and discussions of the results. Section 5 draws conclusions from this study.
The system architecture of AptaCDSS-E
The reviews of CDSS in literature show that very few studies involve field tests of a CDSS and almost none use a naturalistic design in routine clinical settings with real patients. Moreover, the studies mostly concern physicians rather than other clinicians (Kaplan, 2001) . On this point, in the development of AptaCDSS-E we considered both clinicians and physicians equally by providing diagnosis support information to physicians and by providing the information about possible biomarker candidates of disease diagnosis to clinicians. The system can be used for CVD diagnosis in various ways such as a supplementary system for a periodic medical checkup or as a component of a hospital information system.
In AptaCDSSS-E, the patient diagnosis process starts from the doctor's medical examination of a new patient by collecting blood samples when they need these blood analysis processes. Then, an aptamer biochip is created with the serum separated from the patient blood and protein expression levels are scanned. Next, a new work list is created by the scanner interface and analyzed by the decision engine of AptaCDSS-E trained with prior sample sets. The system provides integrated analysis results to the physician, including clinical analysis facts. After the physician's final decisions for a new patient, decision results are saved into the system database as a feedback information for future model updates and refinements.
The system was implemented on the Microsoft Windows platform and has four major components. Fig. 1 shows the overall process of diagnosis with the system and Fig. 2 shows the interface examples of several components of the system.
Scanner interface
The scanner interface (SI) reads the original raw scanner generated data, composes patient chip sample data for each patient, and saves patient samples into the system database creating a new work list. In the SI, one can select specific fields of raw data to construct the patent sample. Users can also check and compare the status of the current chip expression image with standard sample images of cardiovascular patients. For the development of AptaCDSS-E, the ''ratio of median'' field of the original scanner data was selected to reduce negative effects of outlier data points. Fig. 2a shows a screenshot of the SI.
Protocol manager
The protocol manager (PM), running in background, controls and meditates overall communications among the components by performing event scheduling and message delivery. The communication part of the PM was implemented as a component (i.e., ActiveX) and combined with other elements of AptaCDSS-E. Each system component communicates by sending appropriate events to the server part of the PM. The server component also provides several monitoring functions of the component's activity for system management.
AptaCDSS configuration server
The AptaCDSS Configuration Server (ACS) is the key part of AptaCDSS-E. The ACS performs diagnosis decision making with pretrained classifier ensembles of SVM, ANN, DT, and BN models. It also generates visualization information for the diagnosis support client. The ACS provides a preprocessing function of patient samples to normalize an unprocessed initial sample dataset. Through the ACS, one can create basic decision models by setting model-specific parameters along with the proper configuration of ensemble constitution ( Fig. 2c and d) , train classifier models with particular chip samples, test classifier performance with different data, and configure various settings for diagnosis and system logging. The scanner interface (a) reads raw scanner data files generated by chip scanner and converts it to a proper sample format. In the diagnosis support client (b), the Total tab combines the decision result of each classifier and provides a simplified description of the current disease level of the patient. Each classifier tab provides more detailed classifier-specific or causal information to support the classifier's decisions. In the classifier model creation interface (c), basic model parameters can be set. In the ensemble configuration interface (d), the ensemble aggregation approach for each model can be configured. For final decision aggregation, weighted voting of the ensemble's output in terms of their prediction accuracies is provided. In this figure, several fields of confidential patient information of scanner interface and diagnosis support client has been blurred for privacy.
Diagnosis support client
The diagnosis support client (DSC) provides integrated information to both physician and clinician. The disease progress levels of patient are classified into a total of four classes: ''normal (NM)'', ''stable angina (SA)'', ''unstable angina (UA)'', and 14 ''myocardial infarction (MI)''. By using the DSC, clinicians can analyze and select a set of possible biomarker candidates for further detailed experimental validation, and physicians can make use of clinically analyzed information as supplementary diagnosis information. In addition to the supplementary information provided by clinicians, physicians can aided by the prediction results based on the set of prior patient samples. After the final diagnosis is made by the physician, the physician can create and reflect feedback information to the system about unusual or exceptional cases for future reference by summarizing their opinions.
Base classifiers

Decision tree
Decision tree induction is one of the most popular classification methods. It builds a decision tree and classifies the given data and has been successfully applied to a broad range of tasks. A decision tree is a tree in which each nonleaf node denotes a test on an attribute of cases, each branch corresponds to an outcome of the test, and each leaf node denotes a class prediction (see Fig. 3 ). To improve human readability, learned trees can also be re-represented as sets of if-then rules.
Decision trees select the most discriminant features based on the information gain at each stage when growing the tree structure. Consequently, a set of ordered features that make the largest contributions to successful classification are obtained when classifier training is finished. The information gain is calculated with respect to entropy of each attributes, which defined as
where p i is the proportion of outcomes belonging to class i, Values(A) is the set of all possible values for attribute A, and S m is the subset of for which attribute A has value m (i.e., S m = {s 2 SjA(s) = m}). In AptaCDSS-E, expression levels of proteins are discretized into one of four classes before entropy calculation by applying k-means clusteringbased preprocessing (k = 4) to generate comprehensible decision trees. In this project, AptaCDSS-E utilized the C4.5 (Quinlan, 1993) approach from among well-known decision tree induction algorithms for classifying CVD levels of interest and the values of protein expression as the attribute sets.
Neural network
An ANN is a mathematical model consisting of a number of highly interconnected processing elements organized into layers, the geometry and functionality of which have been inspired by that of the human brain. An ANN is trained with the available data samples to explore the relation between inputs and outputs, so that one can reach the proper and accurate outputs when new data are added (Simpson, 1990) . Multilayer perceptrons, a class of supervised neural networks, is one of the most popular neural network models due to its clear architecture and comparably simple learning algorithm, and it is frequently used in MDSS (Bishop, 1995; Ripley, 1996; Yan et al., 2006) . For AptaCDSS-E, an MLP with a sigmoid function for node activation and standard back-propagation (BP) Fig. 3 . A decision tree example for cardiovascular disease diagnosis. In this DT example, patient samples are classified into one of the four target classes by testing the expression value of seven marker proteins. The DT structure and checking markers for classification of patient are obtained by training initial random structured DT with given training set. The marker proteins, such as P1251, are tested in which expression level they belong at each tree level (in this example, the proteins are classified into one of the four expression levels, 0, 1, 2, and 3) for patient diagnosis (classification).
weight learning method were used. The BP algorithm is a widely used training procedure that adjusts the connection weights of the MLP (Rumelhart, Hilton, & Williams, 1986) . In BP, the error terms d k for each network output unit k, o k , and d h for each hidden unit h, o h , are calculated by
where t k is the target value of unit k, w kh is the weight of connection between the kth output unit and hth hidden unit. The network weights are updated by
where Dw ij = gd i x ij . The output layer of MLP comprises of four nodes and each node corresponds to one cardiovascular disease level of interest for prediction. The number of nodes in the input layer varies according to the size of input feature vector determined by feature selection and the number of nodes in hidden layer is determined by user input (for AptaCDSS-E, we used 16 hidden nodes for threelayered MLP). The architecture of the overall neural network classifier is illustrated in Fig. 4 .
Support vector machine
Support vector machines are an effective binary data classification method (Vapnik, 1995) . The key idea of SVMs is the use of a mapping function which projects the given input feature space into a high dimensional feature space to find an optimal hyperplane having the largest margin of separation between different classes with minimum error rate as shown in Fig. 5 .
SVMs use a portion of the data to train the system and find several support vectors that represent the training data. These support vectors will be formed into a model by the SVM, representing each category. For a linearly separable binary classification with an n-dimensional vector x i and the label of the class that vector y i , i.e., fðx i ; y i Þg N i¼1 and y i = {+1, À1}, the SVM separates the two classes of points using the classification decision function f w,b = sign (w AE x + b), where w is an input vector, x is an adaptive weight vector, and b is a bias. SVM finds the parameters w and b for the optimal hyperplane to maximize the geometric margin, 2 kwk ; subject to min w T w 2
For the linearly non-separable case, the minimization problem needs to be modified to allow for the misclassification of data points. A soft margin classifier that allows but penalizes errors by introducing slack variables n l i¼1 as the measurement of violation of the constraints is represented by
where C and k are used to weight the penalizing variables n i , /(x i ) is a non-linear function which maps the input space into a higher dimensional space (i.e., into a Hilbert space). This mapping can be represented as
, where K(AE) is a kernel function. Minimizing the first term of Eq. (6) corresponds to minimizing the VCdimension of the learning machine and minimizing the second term in Eq. (6) controls the empirical risk. The solution of this minimization problem can be found through a Wolfe dual problem with the Lagrangian method. The SVM has several kernel functions that users can apply to solve different problems. A proper inner product kernel function K(x i AE x j ) can solve certain linear inseparable problems without increasing the complexity of the Fig. 4 . The architecture of the three-layered MLP network as a base disease classifier of AptaCDSS-E. For a given patient sample to diagnose, a vector of expression values of selected proteins is fed into the input layer. Each node of output layer corresponds to one target class of diagnosis and the class of the output node with maximum value is selected as a final decision.
calculation and different kernel functions are suited to different problem types. The kernel function can be any function that satisfies Mercer's theorem (Mercer, 1909) ; however, the most popularly used kernel functions are the linear, polynomial, and radial basis functions, and sigmoid kernels. For AptaCDSS-E, we have chosen the polynomial kernel.
Bayesian network
A Bayesian network (Cooper & Herskovits, 1992; Heckerman, Geiger, & Chickering, 1995 ) is a graphical model that represents dependency relationships among variables of interest. It is represented as an annotated directed acyclic graph (DAG) encoding probabilistic relationships among distinctions of concern in an uncertain-reasoning problem. The nodes or the vertices of the DAG represent the random variables in the network while the edges connecting the vertices represent the causal influence of one node on the other. Each node of graph has a probability table representing probabilistic relations with other connected nodes. By using the given network structure, probability table, and some observations of partial variables, an inference for other unobserved variables can be made. Formally, a BN for a given finite set U = {X 1 , . . . , X n } of discrete random variables where each X i may take on values from a finite domain is the pair B = hG, Li. The G is a DAG whose nodes correspond to the random variables X 1 , . . . , X n , and whose edges represent direct dependencies between the variables. The graph structure G encodes the following set of independence statements: each variable X i is independent of its non-descendents, given its parent in G. Standard arguments (Pearl, 1988) shows that any distribution P that satisfies the independence statements encoded in the graph G can be factored as
where Pa i denotes the parents of X i in G.
The second component of the BN, L, is a set of conditional probabilities between the variables in G. The problem of training a BN can be stated as a task of finding an optimal network B s that best matches the given training set D = {u 1 , . . . , u N } i.e., to find a network that maximizes P(B s jD) = P(B s , D)jP(D).
The learning processes of a BN include structure learning of G and parameter learning of L. The structure learning, the optimization problem in the space of the DAGs, finds an appropriate graph structure for the given data Fig. 5 . The hyperplane-based linear separation of binary class data of SVM by feature space mapping. The SVM maximizes its margin of hyperplane in high dimensional feature space by finding the optimal hyperplane using support vectors. For one SVM, a total of six sub-SVMs are used in the manner of ''1 to all'' to perform four-class CVD patient classification. Fig. 6 . The structure of a naïve Bayes model as an initial BN and the example structure result of BN structure learning. The BN of the system starts network structure learning from this naïve Bayes model structure which has n edges connecting target class variable and feature (protein) variables to learn variable dependency for a given data set (a). After structure and parameter learning, the learned BN model is used to diagnose given test samples by deciding one class of the target classes of target class variable (b). In the resulting BN, each edge represents causality between nodes by representing ''underexpression'' (the expression value of a node < threshold t) or ''overexpression'' (the expression value of a node P threshold t). from all possible graph constitutions. Since network structure finding is known to be an NP-hard problem (Heckerman et al., 1995) , various heuristics have been applied in structure learning such as greedy search, greedy search with restart, best-first search, and simulated annealing, etc. In our study, ''greedy search with random restart'' method which is a simple but robust heuristic approach was used to resolve the problem of local optimum convergence. We used the naïve Bayes classifier structure of Fig. 6a as an initial network structure of network learning with this search strategy. This approach modifies its initial simple BN structure by adding, deleting, and switching the directions of the edge in consecutive order and selects a network with highest score among networks obtained by several repeated trials. The fitness of a network structure was evaluated by ''Bayesian Dirichlet and likelihood equivalence'' (BDe) score metric (Heckerman et al., 1995) .
After the network structure learning, conditional probabilities of each variable of the obtained network for given parent nodes are calculated in the extended framework of BDe by calculating sufficient statistics from given data with fixed priors.
Ensemble of classifiers
Need for a classifier ensemble
The complexity and subtlety of microarray expression patterns between CVD patients and normal samples may increase the chance of misclassification when a single classifier is used because a single classifier tends to cover patterns originating from only part of the sample space. Therefore, it would be beneficial if multiple classifiers could be trained in such a way that each of the classifiers covers a different part of the sample space and their classification results were integrated to produce the final classification. Moreover, this combination can reduce the variance of estimation errors and improve the overall classification accuracy (Shin & Markey, 2006) .
Ensemble algorithms such as bagging, boosting, or random forests improve the classification performance by associating multiple base classifiers to work as a ''committee'' for decision-making and any supervised learning algorithm can be used as a base classifier of ensemble (Bauer & Kohavi, 1999) . Ensemble algorithms not only increase the classification accuracy, but also reduce the chances of overtraining since the committee avoids a biased decision by integrating the different predictions from the individual base classifiers. The concept of combining classifiers into ensembles first appeared in work by Nilson (1965) (further described in Sharkey, 1999) , and then extensive studies started in the 1990s.
For this reason, AptaCDSS-E adopted the ensemble approach to generate enhanced results by grouping a set of classifiers of each SVM, ANN, DT, and BN. In this section, we will describe the classifier combination approaches adopted by AptaCDSS-E.
Why ensemble works better
An ensemble of classifiers is a set of classifiers whose individual decisions are combined in some way (typically weighted or unweighted voting) to classify new examples. It is known that ensembles are often much more accurate than the individual classifiers that make them up. An ensemble can be more accurate than its component classifiers only if individual classifiers disagree with one another (Hansen & Salamon, 1990) .
For example, for an ensemble of three classifiers: {h 1 , h 2 , h 3 } and we consider a new case x. If the three classifiers are identical, then when h 1 (x) is wrong, h 2 (x) and h 3 (x) are also wrong. However, if the errors made by the classifiers are uncorrelated, then when h 1 (x) is wrong, h 2 (x) and h 3 (x) might be correct, so that a majority vote correctly classifies x. More precisely, if the error rates of L hypotheses h ' are all equal to p < 1/2 and if the errors are independent, then the probability that the majority vote is wrong is the area under the binomial distribution where more than L/2 hypotheses are wrong. Of course, if the individual hypotheses make uncorrelated errors at rates exceeding 0.5, then the error rate of the voted ensemble increases as a result of the voting. Hence, the key to successful ensemble methods is to construct individual classifiers with error rates below 0.5 whose errors are at least somewhat uncorrelated.
Construction of classifier ensemble
Many approaches for constructing an ensemble of classifiers have been proposed. The most important thing in constructing a classifier ensemble is to make each individual classifier different from the other classifiers as possible. This requirement can be met by using different training sets for different classifiers. In AptaDSS-E, one of the representative methods, bagging (Breiman, 1996) , is used to satisfy this requirement of classifier diversity.
In a bagging, classifiers are trained independently via a bootstrap method and then they are aggregated by an appropriate combination strategy. Bootstrapping generates K replicas {T k (X) j k = 1,. . . , K} of training data by repeated random re-sampling with replacement from the given training data T(X) = {(x i ; y y ) j i = 1,. . . , N}. As a result, each example in the given training set may appear repeatedly or not at all in any particular replica training set. Then, each replicated training set is used to train a certain classifier of an ensemble.
To achieve maximal diversity of ensembles, we can construct ensembles with different classification models. But in this case, it is not easy to compare different classifier models because the difference comes from model-specific characteristics of the models in the ensemble. Furthermore, we need a well-defined objective measure to compare fairly a set of different kind of models. Hence, we construct an ensemble for each classification method with k homogeneous classifiers, but make them different as much as possible by setting initial factors randomly such as weights, structures, and probabilities.
Classifier aggregation
After training the classifiers of each model group, we need to aggregate independently trained classifiers of each group into an appropriate combination method. We considered two types of model combination approaches such as linear (the majority voting and LSE-based weighting) and non-linear (the double-layer hierarchical grouping) combination method (Kim, Pang, Je, Kim, & Bang, 2003) .
Majority voting
One simplest method of classifier combination is majority voting. For f k (k = 1,. . . , K), a decision function of the kth classifier in the classifier ensemble, and c j (j = 1,. . . , C), a label of jth class, the final decision of an ensemble f vote (x) for a given test data x with majority voting is decided by
where t j is the number of classifiers whose decisions are known to jth class and defined by t j = P c(k, j), where c(k, j) is 1 if f k (x) = c j and 0, otherwise.
Least squared error (LSE)-based classifier weighting
The LSE-based weighting of classifiers treats several classifiers in the classifier ensemble with different weights. The weights of different classifiers are assigned in proportional to their classification accuracies. For f k (k = 1,. . . , K), a decision function of the kth classifier in the classifier ensemble which trained with a replica of training data T k ðXÞ ¼ fðx 0 i ; y 0 i Þji ¼ 1; . . . ; N g, the weight vector w can be obtained by w E = A À1 y, where A = (f i (x j )) K·N , and y = (y j ) 1·N . Then, the final decision of the classifier ensemble ′ Fig. 7 . The overall architecture of the decision making part of AptaCDSS-E with multiple classifier ensembles (here we used a total of four ensembles of four different classification models). Each ensemble is constituted with several classifier models of each classification method. The training data are augmented by bagging and fed to each classifier member of ensembles. Final decision is decided by weighted majority vote of each ensemble's decision with respect to their training accuracies. for a given test data vector x with LSE-based weighting is decided by
This weight-based linear combination is also used to combine the decision results of each classifier ensemble with respect to their accuracy on the training data to make the final decision as shown in Fig. 7 .
Hierarchical combination
In hierarchical combination, an additional classifier is used to aggregate the outputs of classifiers of the ensemble. So, this combination consists of a double-layer of classifiers where the outputs of several classifiers in the lower layer feed into an aggregation classifier in the upper layer (Fig. 8) .
For f k (k = 1,. . . , K), a decision function of the kth classifier in the classifier ensemble, and a decision function of the aggregating classifier F, the final decision function of the classifier ensemble f HC (x) for given test data x with the double-layer hierarchical combination is given by f HC ðxÞ ¼ F ðf 1 ðxÞ; f 2 ðxÞ; . . . ; f k ðxÞÞ; ð10Þ
where k is the number of classifiers in the ensemble.
Making the final decision
The final decision in Fig. 7 is decided by combining outputs of all ensembles taking accuracy-based weighted majority vote (i.e., use their training accuracies as their weights). Then, the final class c final among the possible target classes (C, C = 0: Normal, 1: SA, 2: UA, 3: MI) is decided by
where n is the number of classifier ensembles, w i is the weight of ith ensemble, and I i,c is the indicator of ith ensemble, which has 1 if the output class of ensemble is equal to c and 0, otherwise. The c i in Eq. (11) is an advantage variable, predetermined variable by the user, preventing a draw in the vote by giving some advantage to ensembles with respect to the preference of each classification method.
Experimental results and discussion
The experimental steps of aptamer chip-based disease level classification with multiple classifiers are summarized in Fig. 9 . The steps in category A were performed by the data supplier, and in this research we performed the steps with solid border in category B and C with the Apta-CDSS-E. The final experimental verification of discovered possible biomarkers will be conducted in future work.
Data sets
The AptaCDSS-E performs clinical decision support task of cardiovascular disease by analyzing aptamer chip data, which were produced from the patient's blood samples. The advantages of using blood samples include: blood is readily accessible and less expensive to obtain than many other procedures. The disease analysis of AptaCDSS-E is performed on blood-derived products, particularly on serum which is the fluid that remains after clothing proteins are removed from plasma.
Besides the CVD data, we used three additional disease data sets, which include pulmonary complaints, tuberculosis disease, and general cancer collections to overcome the data insufficiency problem and evaluate the generalized classification accuracy of the system for other diseases. Table 1 shows the statistics of CVD and other disease samples used in this study. 
Preprocessing
We constructed chip data using the ''ratio of median'' field of the original scanner generated file to minimize the negative properties of outlier data points. Also, the set of control spots for each chip sample were removed and the missing values are filled with the median value of the sample. Next, the data were transformed by applying logarithm base 2 and a ratio-based normalization method is applied to adjust the means of the samples to zero. By applying this ratio-based normalization we removed the laser channel difference which may occur in chip scanning process.
Feature selection
For the feature selection, the dimension of each disease data set is reduced by applying analysis of variance (ANOVA) and we selected the top 250 proteins according to their significance score (p-value) to build a final classifier inputs. Fig. 10 shows the quality of four disease data sets with respect to their correlation analysis (Pearson correlation) and hierarchical sample clustering results with their full features. The quality of these data sets is refined by discarding non-informative features according to their significance (p-value). By applying this feature selection, we could also reduce the complexities of data processing in each classification model. Table 2 shows the classification accuracy of each classifier and of each classifier ensemble for different ensemble constitution methods for each data set. The classification (prediction) performance was measured by k-fold cross-validation with k = 10 to alleviate the insufficiency of samples. For ensemble-based model, each ensemble is trained with the data set augmented by bagging described in Section 3.3.
Results
In the case of the single classifier-based prediction, the SVM performed best for all data sets and the ANN ranked second among the four different classifiers. The prediction intervals of the classifiers were about 6.8% at least and 12.2% at most. Presumably, the prediction accuracy for ''Tuberculosis disease'' data was relatively low due to the small sample size and poor quality of data.
For the ensemble classifier-based prediction, the SVM and ANN performed very well for all data sets similar to the single classifier case. Especially, the ANN achieved the best prediction accuracy for ''Pulmonary complaints'' data for all ensemble aggregations and SVM achieved the best prediction accuracy for ''General cancer'' data. Interestingly, the BN ensemble with LSE-based weighting aggregation method was the best classifier for ''Tuberculosis diseases''. The maximum prediction interval of overall ensemble method was about 7% ([86.39, 93.42] , for the ensemble with LSE-based weighing for ''GC'' data) and the minimum was about 2.1% ([89.53, 91.64] , for the ensemble with majority vote for ''TBD'' data). The hierarchical classifier combination showed the best performance among the three aggregation methods showing prediction accuracy intervals between about 5.5% ([90.36, 95 .87], for ''CVD'' data) and 2.4% ([90.97, 93 .38], for ''TBD'' data).
By utilizing DT and BN, we obtained decision support information, including causalities among sample features, which can be represented in a human readable and easy to understand structure such as rules or causality networks. Fig. 11 shows a simple BN example with 10 nodes for cardiovascular disease diagnosis trained with CVD data of Table 1 .
In Fig. 11 , the final decision probabilities of four classes in the class node (four classes; 0, 1, 2, and 3 for NM, SA, UA, and MI, respectively) are decided by setting the protein node's expression value to a binary value according to whether the measures expression is greater or less than the sample's median. For the given sample data (i.e., each protein's binary expression level), the example BN diagnoses the current sample as ''Normal (NM)'' class (see the probability bar chart of class node in Fig. 11 ).
In the BN of Fig. 11 , the final diagnosis decision is made by choosing the class of maximum probability value in the class node. The probabilities of each target class in the class node are calculated by multiplying the highest conditional probabilities of all nodes for a given sample of data. Fig. 12 shows the conditional probability tables for each node of BN in Fig. 11 . The probability values of each conditional probability table are calculated by BN learning with the CVD data in Table 1 .
Discussion
The results of the experiment (Table 2) show that an improvement in prediction accuracy of more than about 10% has been achieved by applying the ensemble method. In particular, hierarchical combination of classifiers showed great accuracy improvements, implying that it is one of the desirable classifier combination methods in ensemble construction. Generally, SVMs, the current state-of-the-art classifier, and ANNs, the most widely adopted model for clinical diagnosis application, achieved relatively higher accuracies than other classifiers.
Although SVMs and ANNs achieved the best performance for most data sets, it is not easy to understand how Fig. 11 . The 10-node BN for CVD diagnosis generated by the BN model of AptaCDSS-E. Each node represents one protein selected from 3000 input protein features (250 proteins after preprocessing), and class node represents the final decision of this BN. The probability bar chart of each node represents its cumulative probability quantified by BN training with training samples (DT results are not shown in this paper). Fig. 12 . The conditional probability tables of the BN in Fig. 11 . For each node, the size of table increases as the number of parent nodes increase. they produced diagnosis results because they use non-linear feature mappings and weight compositions. For this reason, they are often referred to as ''black box'' models. Consequently, these models are not appropriate for generating diagnosis support information that can be used by physicians and clinicians to help in their decision making.
In AptaCDSS-E, we adopted DTs and BNs to resolve this difficulty and generate decision support supplementary information displayed by DSC. Generally, DTs generate human readable decision rules and BNs generate causality networks, which can be easily understood by humans. The BN of Fig. 11 shows the causalities of the major 10 proteins selected from the total of 3000 proteins (250 proteins after preprocessing) for the diagnosis of cardiovascular disease. These selected proteins can be regarded as a set of possible biomarkers for CVD diagnosis and can be confirmed as ''real'' biomarkers after further experimental verification. Moreover, this information can be used by clinicians to design new clinical trials by utilizing those proposed possible biomarkers for disease diagnosis.
To summarize, the advantage of using the proposed system is such that physicians can have practical aids in their daily diagnosis with relatively high accuracy and clinicians can find meaningful ''real'' biomarkers by investigating the results produced by AptaCDSS-E.
However, even though we adopted an ensemble-based classifier approach and bagging as a data augmentation strategy to boost prediction accuracies, data sampling techniques cannot overcome coverage limitations inherent to the data set from which the samples are drawn. If the data set does not represent the underlying probability distribution of the population of interest, then even the most sophisticated feature selection based on sampling techniques will end up with an extremely biased subset of features. In case of TBD data, the size of samples was too small, and it seems that the sample data sets did not contain the sample characteristics appropriate for classifying their classes. Consequently, the poor quality of samples led to degradation of overall prediction accuracy for this data set for all classifiers. Therefore, securing more microarray chip samples with relatively good quality and reflecting the underlying characteristics of a disease of concern is one of the most important issues in achieving improved and generalized classification accuracy.
Conclusions
We have presented a classifier ensemble-based clinical decision support system called AptaCDSS-E for disease level prediction with aptamer biochip data. The system employs four different machine learning classifiers, combines the prediction results of each classifier in an ensemble machine, and generates supplementary information for disease diagnosis. The system was trained with four different disease data sets consisting of 242 cases including cardiovascular disease and the data sets were augmented by bagging for classifier ensemble training. The experimental result with cross-validation shows that the proposed system predicts the level of diseases with relatively high accuracy (>94%) and small prediction difference intervals (<6%), showing its usefulness in support of clinical decision making for diagnosis. In particular, causality information among the major 10 proteins for cardiovascular disease diagnosis was found by the system as a candidate set of possible biomarkers, which now require further clinical verification.
